Medicare will pilot an AI-powered prior authorization system that pays companies based on how many claims they reject, marking a troubling shift toward automated healthcare denials that already plague private insurers.
What is Medicare’s WISeR model?
Medicare’s new Wasteful and Inappropriate Service Reduction (WISeR) model reads like something from dystopian fiction. Starting January, AI companies will earn a cut of the money they save by blocking Medicare beneficiaries from their healthcare.
The program essentially creates what one advocate calls “bounty hunters” in the healthcare system.
The current state of AI healthcare denials
The timing couldn’t be worse. Private insurers already deny claims at record rates, with initial denial rates jumping from 10.15% in 2020 to nearly 12% by late 2023. Medicare Advantage plans show even grimmer statistics, with denial rates rising 56% between 2022 and 2023.
These aren’t just numbers on spreadsheets. They represent cancer patients waiting months for treatment while their conditions worsen, elderly patients kicked out of rehabilitation facilities, and families depleting life savings.
How private insurers use AI to reject claims
The private insurance playbook offers a preview of what’s coming. Cigna’s PXDX system lets doctors reject 60,000 claims monthly without opening patient files, spending roughly 1.2 seconds per case. UnitedHealthcare allegedly uses an AI tool with a known 90% error rate.
When appeals succeed 80-90% of the time, you’re not looking at quality control. You’re looking at systematic obstruction betting that sick people won’t fight back.
Here’s the cruel genius: insurers know exactly what they’re doing. Internal documents show companies predict billions in savings from these AI systems. They count on patient exhaustion. Only 0.2% of denied claims get appealed.
The math is coldly profitable.
Problems with human oversight in AI denials
Medicare officials promise human clinicians will make final denial decisions, but that safeguard rings hollow.
Cigna doctors already rubber-stamp AI recommendations without review. When your performance metrics reward speed over accuracy, when you’re processing 50 denials in 10 seconds, human oversight becomes theater.
Technical limitations and bias in medical AI
The technology itself remains deeply flawed. Recent research shows AI medical systems can go haywire from a single typo, exhibit gender bias by telling women not to seek care more often than men, and fundamentally lack the nuance for complex medical decisions.
Yet we’re handing these systems unprecedented power over healthcare access while their owners profit from every rejection.
Why Medicare’s approach contradicts its mission
What makes this especially galling is the stated justification. Yes, healthcare waste exists. But turning AI companies into commissioned denial agents isn’t reform, it’s weaponizing technology against patients.
California recently passed legislation requiring human physicians to review all AI-driven denials, recognizing the danger. Meanwhile, Medicare marches in the opposite direction.
Geographic scope and expansion risks
The six pilot states – New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington – become testing grounds for a model that could expand nationwide.
Officials claim they’ll only target “wasteful” procedures like steroid injections for pain relief. But once the infrastructure exists, once companies taste those billions in potential savings, containment becomes fantasy.
This represents a fundamental betrayal of Medicare’s promise. The program exists precisely because private insurance failed vulnerable populations. Now Medicare imports those same failures, dressed up as innovation.
The elderly and disabled, who fled to Medicare for refuge from private insurance cruelty, find the walls closing in.
Future implications for Medicare beneficiaries
Medicare’s AI experiment signals a dark turn for American healthcare. When government programs start paying bounties for healthcare denials, we’ve crossed a line.
The question isn’t whether this technology will expand beyond its initial scope – history shows it will. The question is whether we’ll accept a future where algorithms and profit incentives determine who gets care and who gets abandoned.
The infrastructure being built today won’t stay confined to six states or twelve procedures. Once normalized, automated denial becomes the default. Medicare beneficiaries deserve better than becoming test subjects for Silicon Valley’s healthcare disruption.
FAQs
What is Medicare’s WISeR model and how does it work?
Medicare’s Wasteful and Inappropriate Service Reduction (WISeR) model launches in January, paying AI companies a percentage of money saved by blocking Medicare beneficiaries’ healthcare claims. Companies essentially become “bounty hunters” earning profits from healthcare denials.
How are private insurers currently using AI to deny claims?
Private insurers use AI systems like Cigna’s PXDX, which allows doctors to reject 60,000 claims monthly in 1.2 seconds per case without reviewing patient files. UnitedHealthcare allegedly uses AI tools with 90% error rates to systematically obstruct claims.
What are the main problems with AI-driven healthcare denials?
AI medical systems exhibit severe flaws including going haywire from single typos, showing gender bias against women seeking care, and lacking nuance for complex medical decisions. Human oversight often becomes meaningless theater when doctors rubber-stamp AI recommendations for speed.
Which states will pilot Medicare’s AI denial program?
Six states will serve as testing grounds for the WISeR model: New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington. Officials claim they’ll only target “wasteful” procedures like steroid injections for pain relief initially.
Why does this program contradict Medicare’s original mission?
Medicare was created because private insurance failed vulnerable populations, yet now imports those same failures. The program transforms from protecting elderly and disabled patients into weaponizing technology against them through commissioned denial agents seeking profit from healthcare rejections.